Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03731364 · ClinicalTrials.gov registry record · Phase 2
Study of CA-008 (Vocacapsaicin) in Total Knee Arthroplasty
A Phase 2 study, sponsored by Concentric Analgesics.
- Completed
- Registry status
- Phase 2
- Development phase
- 55
- Enrollment target
NCT03731364 is a Phase 2 study that has completed, run by Concentric Analgesics. The registered enrollment target is 55 participants.
The verdict
NCT03731364, a Phase 2 study, has completed, sponsored by Concentric Analgesics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 55 participants
- Enrollment target
Study Summary
This is a two-part, Phase 2, multi-center, randomized, double-blind, placebo-controlled, parallel design study of CA-008 (vocacapsaicin) vs. placebo injected/instilled during an elective TKA.
Interventions
- DRUG Placebo
- DRUG CA-008
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2018-10-29 |
| Est. Completion | 2019-05-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03731364
The ClinicalTrials.gov registry entry for NCT03731364 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Concentric Analgesics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03731364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03731364 about?
NCT03731364 is a clinical study titled "Study of CA-008 (Vocacapsaicin) in Total Knee Arthroplasty". This is a two-part, Phase 2, multi-center, randomized, double-blind, placebo-controlled, parallel design study of CA-008 (vocacapsaicin) vs. placebo injected/instilled during an elective TKA.
What is the current status of trial NCT03731364?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 55 participants. The study started on 2018-10-29. Estimated completion is 2019-05-31.
What interventions are being tested in trial NCT03731364?
The interventions under investigation include: Placebo (DRUG), CA-008 (DRUG).
Who is sponsoring clinical trial NCT03731364?
This trial is sponsored by Concentric Analgesics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.